Clinical Trial Update: Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating whether inhaled acetylcysteine reduces the incidence and delays the onset of ventilator-associated pneumonia in crit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Acetylcysteine inhalation (N-acetylcysteine inhalation)

Snippet

Sponsor: Sarah Rabie Mohamed Adly | Conditions: Ventilation Acquired Pneumonia | Phase 4 | Status: RECRUITING